Our study deepened the understanding of the function of SLMO2 in tumorigenesis, highlighted the potential of SLMO2 as a pan-cancer prognostic and immunological biomarker, and explored the underlying mechanisms of SLMO2 in different cancers. Here, PRELID3B is linked to cancer.